Aldosterone antagonists for preventing the progression of chronic kidney disease
Author:
Publisher
John Wiley & Sons, Ltd
Reference27 articles.
1. Regression of existing glomerulosclerosis by inhibition of aldosterone;Aldigier;Journal of the Amercian Society of Nephrology,2005
2. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease;Bianchi;Kidney International,2006
3. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy;Brenner;New England Journal of Medicine,2001
4. Retarding the progression of renal disease;Brenner;Kidney International,2003
5. Double-blind, placebo-controlled study on the effect of the aldosterone receptor antagonist spironolactone in patients who have persistent proteinuria and are on long-term angiotensin-converting enzyme inhibitor therapy, with or without an angiotensin II receptor blocker;Chrysostomou;Clinical Journal of The American Society of Nephrology: CJASN,2006
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cardiorenal benefits of mineralocorticoid antagonists in CKD and type 2 diabetes;Herz;2022-09-12
2. Yishen Qingli Heluo Granule in the Treatment of Chronic Kidney Disease: Network Pharmacology Analysis and Experimental Validation;Drug Design, Development and Therapy;2022-03
3. Aldosterone antagonists in addition to renin angiotensin system antagonists for preventing the progression of chronic kidney disease;Cochrane Database of Systematic Reviews;2020-10-27
4. RESISTANT ARTERIAL HYPERTENSION IN PATIENTS WITH CHRONIC KIDNEY DISEASE: PREVALENCE, PROGNOSTIC SIGNIFICANCE, REASONS AND APPROACHES TO ANTIHYPERTENSIVE THERAPY;Nephrology (Saint-Petersburg);2019-02-06
5. RAAS Blockade as First-Line Antihypertensive Therapy among People with CKD;Renin-Angiotensin System - Past, Present and Future;2017-07-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3